ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00162110
Recruitment Status : Completed
First Posted : September 13, 2005
Last Update Posted : October 28, 2015
Sponsor:
Collaborator:
ImClone LLC
Information provided by:
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2007
  Actual Study Completion Date : January 2007